Efficacy and safety of long-acting beta-2 agonist and long-acting muscarinic antagonist combinations in patients with chronic obstructive pulmonary disease: meta-analysis of phase 3 randomized trials
Not Applicable
- Conditions
- chronic obstructive pulmonary disease
- Registration Number
- JPRN-UMIN000026496
- Lead Sponsor
- Showa University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 5000
Inclusion Criteria
Not provided
Exclusion Criteria
patients with bronchial asthma, or with severe cardiovascular disease
Study & Design
- Study Type
- Others,meta-analysis etc
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method changes in forced expiratory volume in 1 second (FEV1.0) from baseline
- Secondary Outcome Measures
Name Time Method St. George's respiratory questionnaire scores, serious adverse events, all cardiovascular events, major cardiovascular events, non-major cardiovascular events, COPD worsening, nasopharyngitis, and all adverse events